AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 171 min read$AEHR

SCOTT GEOFFREY GATES sold $1.6M of AEHR (indirect holdings)

SCOTT GEOFFREY GATES (Director) sold 20,000 indirectly-held shares of AEHR TEST SYSTEMS (AEHR) at $82.13 ($1.64M total) on 2026-07-16.

Original reporting
SEC EDGAR · SCOTT GEOFFREY GATES
Published Jul 17, 2026, 6:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 17, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this filing alone does not change AEHR’s operating outlook.

02

Market read

A director’s open-market sale at $82.1325 is disclosed, which may slightly affect sentiment but provides no new fundamental information.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, which can increase interpretive noise, but it still lacks any linkage to earnings, guidance, or business developments.

Relevance 6/10Novelty 3/10Timing: after-hours filing timestamp on 2026-07-17 for a 2026-07-16 sale

Background

The article is an SEC Form 4 insider transaction disclosure for AEHR director Scott Geoffrey Gates.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

Director Scott Geoffrey Gates filed an open-market sale of 20,000 AEHR shares at $82.1325 on 2026-07-16, leaving 30,000 shares.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

Form 4 insider sales are common and the filing provides transaction details but no new company-specific operating or guidance information.

Market effects

Sector

None; this is company-specific insider transaction data.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

The sale may be unrelated to company outlook (taxes, diversification, or pre-existing personal liquidity needs), so price impact may be overstated.

Key entities

  • issuer
    AEHR

    AEHR Test Systems, the company whose director insider sale was disclosed.

  • insider
    Scott Geoffrey Gates

    Director of AEHR who sold 20,000 shares in an open-market transaction.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AEHR insider trading history →

Related articles

SEP 4
$AEHRMed

AEHR Stock Rides AI Order Wave Amid Volatility

Aehr Test Systems (AEHR) stock rose 13.28% following strong earnings and a positive outlook for semiconductor test demand. The company reported $50M in revenue, $18.8M in quarterly revenue, and a net income of $1.39M. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI production. The stock has shown volatility, with a recent drop of 9.5-10.5% in a single session. Insiders have sold shares but maintain significant holdings. AEHR is actively presenting a

stockstotrade.com2 min
SEP 4
$AEHRHigh

AEHR Stock Rallies As AI Orders And Wall Street Support Build

Aehr Test Systems (AEHR) stock rose 11.71% due to strong AI-related demand. The company reported $18.8M in revenue with a 35.3% gross margin. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI chip production. The company has a strong balance sheet and a $22M follow-on order from a major customer.

stockstotrade.com2 min
SEP 4
$AEHRHigh

AEHR Stock Rallies As AI Test Orders And Wall Street Support Grow

Aehr Test Systems (NASDAQ: AEHR) stock rose 11.73% on growing AI test demand. The company secured a $22M follow-on order for AI chip testing equipment. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's unique position in AI production testing. The stock has high volatility, with a strong balance sheet but negative EBIT margins.

timothysykes.com2 min